Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Swine Vaccines Market

Swine Vaccines Market Trends

Report ID: GMI10445
Published Date: Jul 2024
Report Format: PDF

Download Free Sample

Swine Vaccines Market Trends

The growing consumption of pork is a major trend driving the swine vaccines industry. According to World Population Review’s Pork Consumption Data 2024, the current pork consumption stands at 112.6 kilotons, with an expected rise to 129 kilotons by 2031. As pork demand rises globally, particularly in regions like Asia-Pacific, Europe, and North America, swine producers are compelled to maintain healthy and productive herds.
Diseases such as PRRS, ASF, and PCV2 pose significant threats to swine health, impacting growth rates, reproductive efficiency, and meat quality. To prevent these diseases and meet market demands, producers are increasingly adopting vaccination programs.
Additionally, consumer concerns about food safety and animal welfare are growing, emphasizing the need for healthier herds. Vaccinated animals are less likely to transmit diseases, resulting in safer meat products. Thus, this trend further supports the adoption of swine vaccines, driving market growth.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global swine vaccines industry was valued at USD 1.6 billion in 2023 and is anticipated to record a CAGR of 5.3% through 2032, backed by the increasing prevalence of swine diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS), Porcine Circovirus Type 2 (PCV2), and African Swine Fever (ASF).

The inactivated vaccines segment accounted for USD 568.4 million in 2023, owing to their proven track record in preventing swine diseases, along with fewer side effects and adverse reactions, leading to widespread acceptance and trust among farmers and veterinarians.

In 2023, North America market was valued at USD 633.6 million and is expected to record a CAGR of 5.1% from 2024 to 2032, backed by the advanced veterinary infrastructure, supporting efficient vaccine distribution, administration, and monitoring, ensuring high vaccination coverage and effectiveness.

Ceva Sante Animale, Elanco Animal Health Incorporated, HIPRA, Indian Immunologicals Limited, Merck & Co., Inc., Phibro Animal Health Corporation, Vaxxinova, Virbac, and Zoetis Inc. among others.